Aveanna Healthcare (AVAH) Competitors $5.84 +0.04 (+0.69%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AVAH vs. PNTG, AHCO, APR, VMD, TLMD, GH, OPCH, SHC, BTSG, and VCYTShould you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include The Pennant Group (PNTG), AdaptHealth (AHCO), Apria (APR), Viemed Healthcare (VMD), SOC Telemed (TLMD), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), and Veracyte (VCYT). These companies are all part of the "medical" sector. Aveanna Healthcare vs. The Pennant Group AdaptHealth Apria Viemed Healthcare SOC Telemed Guardant Health Option Care Health Sotera Health BrightSpring Health Services Veracyte Aveanna Healthcare (NASDAQ:AVAH) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Does the MarketBeat Community favor AVAH or PNTG? The Pennant Group received 15 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. Likewise, 47.06% of users gave The Pennant Group an outperform vote while only 38.46% of users gave Aveanna Healthcare an outperform vote. CompanyUnderperformOutperformAveanna HealthcareOutperform Votes2538.46% Underperform Votes4061.54% The Pennant GroupOutperform Votes4047.06% Underperform Votes4552.94% Do analysts rate AVAH or PNTG? Aveanna Healthcare presently has a consensus price target of $4.27, indicating a potential downside of 26.94%. The Pennant Group has a consensus price target of $38.25, indicating a potential upside of 22.83%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts plainly believe The Pennant Group is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aveanna Healthcare 2 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75The Pennant Group 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has stronger valuation and earnings, AVAH or PNTG? The Pennant Group has lower revenue, but higher earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAveanna Healthcare$1.90B0.60-$134.52M-$0.34-17.18The Pennant Group$544.89M1.96$13.38M$0.6845.79 Which has more risk and volatility, AVAH or PNTG? Aveanna Healthcare has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Does the media prefer AVAH or PNTG? In the previous week, The Pennant Group had 4 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for The Pennant Group and 0 mentions for Aveanna Healthcare. The Pennant Group's average media sentiment score of 1.10 beat Aveanna Healthcare's score of 0.00 indicating that The Pennant Group is being referred to more favorably in the news media. Company Overall Sentiment Aveanna Healthcare Neutral The Pennant Group Positive Is AVAH or PNTG more profitable? The Pennant Group has a net margin of 3.24% compared to Aveanna Healthcare's net margin of -3.32%. The Pennant Group's return on equity of 13.47% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Aveanna Healthcare-3.32% N/A -0.89% The Pennant Group 3.24%13.47%3.81% Do institutionals and insiders hold more shares of AVAH or PNTG? 88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 7.8% of Aveanna Healthcare shares are held by insiders. Comparatively, 5.8% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryThe Pennant Group beats Aveanna Healthcare on 14 of the 18 factors compared between the two stocks. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get Aveanna Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVAH vs. The Competition Export to ExcelMetricAveanna HealthcareHome health care services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13B$2.97B$5.38B$8.84BDividend YieldN/A0.37%5.13%4.09%P/E Ratio-17.1828.17102.4617.58Price / Sales0.601.201,234.85158.43Price / Cash10.0616.5940.4736.33Price / Book-7.212.597.096.50Net Income-$134.52M-$57.02M$119.65M$226.22M7 Day Performance4.85%2.21%2.06%3.76%1 Month Performance14.29%-0.49%-2.46%4.63%1 Year Performance153.91%22.32%33.95%29.20% Aveanna Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVAHAveanna Healthcare0.4915 of 5 stars$5.84+0.7%$4.27-26.9%+153.9%$1.13B$1.90B-17.1833,500PNTGThe Pennant Group3.6624 of 5 stars$30.50-0.9%$38.25+25.4%+126.5%$1.05B$544.89M44.855,791Positive NewsAHCOAdaptHealth3.0323 of 5 stars$9.89+1.7%$11.67+18.0%+15.9%$1.33B$3.20B-5.9910,700Analyst ForecastAPRApriaN/A$37.50flatN/AN/A$1.34B$1.15B0.006,080VMDViemed Healthcare2.1033 of 5 stars$8.71+2.0%N/A+11.9%$338.97M$183.01M31.74630Positive NewsTLMDSOC TelemedN/A$3.00flatN/AN/A$302.52M$94.44M-5.26226GHGuardant Health3.9877 of 5 stars$31.09+1.3%$40.60+30.6%+40.6%$3.84B$563.95M-7.311,779OPCHOption Care Health4.9817 of 5 stars$22.46+2.7%$30.83+37.3%-23.3%$3.82B$4.30B18.877,802Positive NewsSHCSotera Health4.2362 of 5 stars$12.41-6.1%$16.50+33.0%-6.6%$3.52B$1.05B49.643,000Analyst ForecastHigh Trading VolumeBTSGBrightSpring Health Services2.8925 of 5 stars$18.75-0.2%$16.79-10.4%N/A$3.26B$8.83B-72.0835,000Positive NewsVCYTVeracyte4.1662 of 5 stars$38.94-0.7%$41.25+5.9%+51.6%$3.02B$361.05M-261.33790 Related Companies and Tools Related Companies The Pennant Group Competitors AdaptHealth Competitors Apria Competitors Viemed Healthcare Competitors SOC Telemed Competitors Guardant Health Competitors Option Care Health Competitors Sotera Health Competitors BrightSpring Health Services Competitors Veracyte Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AVAH) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aveanna Healthcare Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aveanna Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
